# The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia

> **NCT07151612** · PHASE4 · COMPLETED · sponsor: **Shanxi Eye Hospital** · enrollment: 62 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** Esculin and Digitalisglycosides Eye Drops
- **DRUG:** Normal saline solution

## Key facts

- **NCT ID:** NCT07151612
- **Lead sponsor:** Shanxi Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-04
- **Primary completion:** 2025-10-08
- **Final completion:** 2025-10-10
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07151612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07151612, "The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07151612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*